A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer-Reference-Cited by-同舟云学术

A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer

Published:2009-06 Issue:6 Volume:4 Page:741-745
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Fukuda Minoru,Nakamura Yoichi,Kasai Takashi,Nagashima Seiji,Nakatomi Katsumi,Doi Seiji,Nakano Hirofumi,Takatani Hiroshi,Fukuda Masaaki,Kinoshita Akitoshi,Soda Hiroshi,Tsukamoto Kazuhiro,Oka Mikio,Kohno Shigeru

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. A monthly report of population vital statistics in Japan (Ministry of Health, Labour, and Welfare).

2. Diagnosis and treatment of lung cancer;Detterbeck,2000

3. Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat;Aisner;J Clin Oncol,1996

4. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

5. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer;Hanna;J Clin Oncol,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis;Therapeutic Advances in Medical Oncology;2020-01

2. Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium;Lung Cancer;2018-03

3. Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies;American Journal of Clinical Oncology;2017-08

4. A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer;Cancer Chemotherapy and Pharmacology;2014-07-18

5. Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer;Chemotherapy;2014